The latest closing stock price for Connect Biopharma Holdings as of September 18, 2024 is 1.18.
An investor who bought $1,000 worth of Connect Biopharma Holdings stock at the IPO in 2021 would have $-936 today, roughly -1 times their original investment - a -60.09% compound annual growth rate over 3 years.
The all-time high Connect Biopharma Holdings stock closing price was 28.50 on August 10, 2021.
The Connect Biopharma Holdings 52-week high stock price is 2.84, which is 140.7% above the current share price.
The Connect Biopharma Holdings 52-week low stock price is 0.55, which is 53.4% below the current share price.
The average Connect Biopharma Holdings stock price for the last 52 weeks is 1.30.
An investor who bought $1,000 worth of Connect Biopharma Holdings stock at the IPO in 2021 would have $-936 today, roughly -1 times their original investment - a -60.09% compound annual growth rate over 3 years.
The all-time high Connect Biopharma Holdings stock closing price was 28.50 on August 10, 2021.
The Connect Biopharma Holdings 52-week high stock price is 2.84, which is 140.7% above the current share price.
The Connect Biopharma Holdings 52-week low stock price is 0.55, which is 53.4% below the current share price.
The average Connect Biopharma Holdings stock price for the last 52 weeks is 1.30.